Citation Impact
Citing Papers
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel
2003
Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters
2002
Inflammation and cancer
2002 StandoutNature
Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome
1997
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
2003
Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up
1995
Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line
1990
The biology and management of non-small cell lung cancer
2018 StandoutNature
Hepatocellular carcinoma with and without cirrhosis
1989
Classification of primary cutaneous T‐cell lymphomas
1994
Performance status assessment in cancer patients
1990
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Prognostic factor analysis in mycosis fungoides/Sézary syndrome
1999
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the working formulation of non-Hodgkin's lymphomas for clinical usage
1994
Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer
2013
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
1999
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma.
1991
Intravascular Large Cell Lymphoma Coexisting Within Hemangiomas of the Skin
1997
Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?
2005
Expression of Multidrug Resistance Gene in Human Cancers
1989
Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor.
1995
Management of Hepatocellular Carcinoma *
2005 Standout
Interferon treatment of cutaneous T‐cell lymphoma
1993
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
1997
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
1995
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
1998 StandoutNobel
Prognostic Factors in Patients With Hepatocellular Carcinoma Receiving Systemic Chemotherapy
1992
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party
1997
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary Syndrome
1988
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Treatment of Cutaneous T Cell Lymphoma
2002
Elevated expression of Annexin II (Lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line
1992
Response criteria for phase II studies of supratentorial malignant glioma.
1990 Standout
HIV infection does not require endocytosis of its receptor, CD4
1988 StandoutNobel
Expression of Cytotoxic Proteins by Neoplastic T Cells in Mycosis Fungoides Increases with Progression from Plaque Stage to Tumor Stage Disease
1999
Therapy of Cutaneous Lymphoma – Current Practice and Future Developments
2003
Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas
2003
Primary Cutaneous T-Cell Lymphomas
2006
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy
1992
Meta-analysis when only the median survival times are known: A comparison with individual patient data results
2005
Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients
1990
Sézary syndrome: Diagnosis, prognosis, and critical review of treatment options
1990
Cryosurgery as a treatment for advanced stage hepatocellular carcinoma
1998
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
1990 StandoutNobel
Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients
1995
EMERGING NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMA
2000
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sézary syndrome
1993
Analysis of T-Cell Receptor Gene Rearrangement in Lymph Nodes of Patients With Mycosis Fungoides
1998
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Transformation of Mycosis Fungoides: T-Cell Receptor β Gene Analysis Demonstrates a Common Clonal Origin for Plaque-Type Mycosis Fungoides and CD30+ Large-Cell Lymphoma
1993
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
2001 Standout
Peripheral T- cell lymphomas: diagnosis and management
2003
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
1991 StandoutNobel
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
1987 StandoutScience
Treatment of Cutaneous T-Cell Lymphoma
1985
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
1986 StandoutNobel
Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from Southern Africa
1981
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
1984 StandoutScienceNobel
Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.
1984 StandoutNobel
Prognosis and Staging of Cutaneous T-cell Lymphoma
1995
Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma
2003
Nucleotide sequence of the human N-myc gene.
1986 StandoutNobel
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
1983 Nature
The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification.
1991
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
1985 Standout
A New International Staging System for Lung Cancer
1986
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
2003
Hepatocellular Carcinoma
1988
The chronology of AIDS research
1987 StandoutNatureNobel
Interferon in the Treatment of Cutaneous T-cell Lymphoma
1995
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
1999
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc
1984 StandoutNatureNobel
Gene Amplification of c- myc and N- myc in Small Cell Carcinoma of the Lung
1986 Science
DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc.
1989 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.
1984 StandoutNobel
Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)
1983 StandoutScienceNobel
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
1990
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
1980 Standout
Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes
1984 StandoutScienceNobel
Systematic reviews of trials and other studies.
1998
Viruses in Human Cancers
1991 StandoutScienceNobel
Phase Ii Study of Transarterial Embolization in European Patients With Hepatocellular Carcinoma: Need for Controlled Trials
1994
Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin
1979 StandoutNobel
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma
2001
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Lymph Node Histopathologic Findings in Cutaneous T-Cell Lymphoma: A Prognostic Classification System Based on Morphologic Assessment
1992
The Karnofsky performance status scale: An examination of its reliability and validity in a research setting
1984
Clinical Characteristics and Outcome of Patients With Extracutaneous Mycosis Fungoides
2001
Histologic assessment of lymph nodes in mycosis fungoides/sézary syndrome (cutaneous T-cell lymphoma): Clinical correlations and prognostic import of a new classification system
1985
Oncogene Amplification in Tumor Cells
1986
Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS
1984 StandoutScience
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
1998
In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia
1997
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
1998
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Clinical Staging for Cutaneous T-Cell Lymphoma
1984
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Molecular Biology Techniques for the Diagnosis of Cutaneous T-Cell Lymphoma
1994
Prospective Staging Evaluation of Patients with Cutaneous T-Cell Lymphomas
1980
Molecular cloning of cDNA encoding human interleukin-2 receptor
1984 StandoutNatureNobel
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
The protein encoded by the human proto-oncogene c-myc.
1984 StandoutNobel
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
1984 StandoutScience
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Blast crisis of chronic granulocytic leukemia
1977
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of Daniel C. Ihde being referenced
Advances in small cell bronchogenic carcinoma.
1977
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.
1988
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
1991
Correlation of In Vitro Drug-Sensitivity Testing Results With Response to Chemotherapy and Survival in Extensive-Stage Small Cell Lung Cancer: A Prospective Clinical Trial
1990
Clinical trials in primary hepatocellular carcinoma: current status and future directions
1988
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
1990
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
1994
NCI-navy medical oncology branch cell line data base
1996
A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis Fungoides
1989
MDR1 Gene Expression in Lung Cancer
1989
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
1996
Chemotherapy of Lung Cancer
1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
1992
Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer
1983
The clinical behavior of „mixed” small cell/large cell bronchogenic carcinoma compared to „pure” small cell subtypes
1982
Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
1979
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival
1985
Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.
1983
Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.
1987
Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer.
1981
The role of recombinant interferon alfa-2a in the therapy of cutaneous t-cell lymphomas
1986
Hepatic involvement in the cutaneous T-cell lymphomas. Results of percutaneous biopsy and peritoneoscopy
1980
Delayed hypersensitivity skin testing as a prognostic indicator in patients with small cell lung cancer
1983
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.
1987
Clinical manifestations of hepatoma
1974
Therapy of small cell lung cancer: a perspective on two decades of clinical research.
1988
Recombinant interferon alfa-2a, an active agent in advanced cutaneous t-cell lymphomas
1987
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up.
1986
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
1992
Splenectomy in the Chronic Phase of Chronic Granulocytic Leukemia
1976
Carcinomatous Leptomeningitis in Small Cell Lung Cancer
1982
CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival
1979